Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
22 Results for "
dioxane
" in MedChemExpress (MCE) Product Catalog:
Products (22)
22 Results for "dioxane" in MCE Product Catalog:
製品番号: HY-W004661
CAS 番号: 23147-58-2
別名: Hydroxy Acetaldehyde
Target:
製品番号: HY-134611
CAS 番号: 13382-47-3
別名: β-hydroxyethoxyacetic acid; HEAA
Target:
研究分野:
(2-Hydroxyethoxy)acetic acid (β-hydroxyethoxyacetic acid) is the main urinary metabolite of 1,4-Dioxane. (2-Hydroxyethoxy)acetic acid is a reliable and sensitive shortterm biomarker in urine .
製品番号: HY-W014316
CAS 番号: 30007-47-7
5-Bromo-5-nitro-1,3-dioxane is a broad-spectrum antimicrobial agent active against Gram-positive bacteria, Gram-negative bacteria and fungi. 5-Bromo-5-nitro-1,3-dioxane oxidizes free thiol groups to their corresponding disulfides. 5-Bromo-5-nitro-1,3-dioxane induces intracellular substance leakage in Escherichia coli and Staphylococcus aureus. 5-Bromo-5-nitro-1,3-dioxane modulates the oxygen consumption of Escherichia coli and Staphylococcus aureus .
製品番号: HY-W074326
CAS 番号: 4480-83-5
製品番号: HY-W004078
CAS 番号: 696-60-6
Category:
other families Monophenols Metabolic Disease Phenols Plants Endogenous metabolite Disease Research Fields
Target:
製品番号: HY-W287562
CAS 番号: 3709-27-1
別名: 5-Benzyl-Meldrum's acid
Target:
研究分野:
5-Benzyl-2,2-dimethyl-1,3-dioxane-4,6-dione (5-Benzyl-Meldrum's acid) is a drug intermediate for synthesis of various active compounds.
製品番号: HY-W767601
CAS 番号: 2122245-03-6
別名: L-Lactide-13C2
製品番号: HY-W111914
CAS 番号: 1120-97-4
別名: 4-Methyl-m-dioxane
Category:
Target:
製品番号: HY-W014316R
CAS 番号: 30007-47-7
Target:
研究分野:
5-Bromo-5-nitro-1,3-dioxane (Standard) is the analytical standard of 5-Bromo-5-nitro-1,3-dioxane (HY-W014316). This product is intended for research and analytical applications. 5-Bromo-5-nitro-1,3-dioxane is a broad-spectrum antimicrobial agent active against Gram-positive bacteria, Gram-negative bacteria and fungi. 5-Bromo-5-nitro-1,3-dioxane oxidizes free thiol groups to their corresponding disulfides. 5-Bromo-5-nitro-1,3-dioxane induces intracellular substance leakage in Escherichia coli and Staphylococcus aureus. 5-Bromo-5-nitro-1,3-dioxane modulates the oxygen consumption of Escherichia coli and Staphylococcus aureus .
製品番号: HY-W009917
CAS 番号: 33884-43-4
製品番号: HY-W759459
別名: 2,2-Dimethyl-1,3-dioxane-4,6-dione-13C3
製品番号: HY-126185
CAS 番号: 53983-00-9
Target:
研究分野:
Nibroxane is an orally active antibacterial agent. Nibroxane can be metabolized to 2-methyl-5-nitro-m-dioxane in mice .
製品番号: HY-W004078R
CAS 番号: 696-60-6
製品番号: HY-W053546R
CAS 番号: 502-97-6
Target:
1,4-Dioxane-2,5-dione (Standard) is the analytical standard of 1,4-Dioxane-2,5-dione. This product is intended for research and analytical applications.
製品番号: HY-W344522
CAS 番号: 766-20-1
Category:
Target:
製品番号: HY-W004661R
CAS 番号: 23147-58-2
別名: Hydroxy Acetaldehyde (Standard)
Category:
製品番号: HY-W725459
製品番号: HY-W382360
CAS 番号: 1174047-11-0
Target:
研究分野:
5-(2-(4-Fluorophenyl)acetyl)-2,2-dimethyl-1,3-dioxane-4,6-dione is a drug intermediate for synthesis of various active compounds.
製品番号: HY-W778954
CAS 番号: 1436560-86-9
別名: (2,2-Dimethyl-[1,3] dioxane-4-yl)-methanol-13C3; (4RS)-2,2-Dimethyl-1,3-dioxolane-4-methanol-13C3; (RS)-Solketal-13C3; (±)-1,2-O-Isopropylideneglycerol-13C3; (±)-2,2-Dimethyl-1,3-dioxolane-4-methanol-13C3; (±)-Glycerol 1,2-acetonide-13C3; Solketa-13C3l
- 1
- 2
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
